In conclusion, our data offer an evidence that the MG and CA combination from BHGZD may interact with TLR4/PI3K/AKT/NFκB signaling to inhibit NLRP3 inflammasome activation and modulate pyroptosis, which provides the novel representative BACs and pharmacological mechanisms of BHGZD against active RA (Figure 7). Here, NFKB1 is linked to rheumatoid arthritis.